nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—CDA—Pyrimidine metabolism—DPYD—attention deficit hyperactivity disorder	0.0323	0.0762	CbGpPWpGaD
Gemcitabine—CMPK1—forebrain—attention deficit hyperactivity disorder	0.0274	0.0475	CbGeAlD
Gemcitabine—CDA—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.025	0.059	CbGpPWpGaD
Gemcitabine—SLC29A2—cardiovascular system—attention deficit hyperactivity disorder	0.0244	0.0422	CbGeAlD
Gemcitabine—CMPK1—cardiovascular system—attention deficit hyperactivity disorder	0.0232	0.0402	CbGeAlD
Gemcitabine—CMPK1—Nucleotide metabolism—DPYD—attention deficit hyperactivity disorder	0.0203	0.048	CbGpPWpGaD
Gemcitabine—RRM1—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.019	0.0447	CbGpPWpGaD
Gemcitabine—DCK—Pyrimidine metabolism—DPYD—attention deficit hyperactivity disorder	0.0188	0.0444	CbGpPWpGaD
Gemcitabine—CMPK1—midbrain—attention deficit hyperactivity disorder	0.0181	0.0314	CbGeAlD
Gemcitabine—RRM2—cardiovascular system—attention deficit hyperactivity disorder	0.0179	0.031	CbGeAlD
Gemcitabine—RRM1—forebrain—attention deficit hyperactivity disorder	0.0176	0.0305	CbGeAlD
Gemcitabine—POLD1—cerebellum—attention deficit hyperactivity disorder	0.0175	0.0304	CbGeAlD
Gemcitabine—SLC29A1—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.0173	0.0409	CbGpPWpGaD
Gemcitabine—RRM2—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.0156	0.0368	CbGpPWpGaD
Gemcitabine—CMPK1—nervous system—attention deficit hyperactivity disorder	0.0149	0.0258	CbGeAlD
Gemcitabine—RRM1—cardiovascular system—attention deficit hyperactivity disorder	0.0148	0.0258	CbGeAlD
Gemcitabine—SLC29A2—cerebellum—attention deficit hyperactivity disorder	0.0147	0.0255	CbGeAlD
Gemcitabine—CMPK1—central nervous system—attention deficit hyperactivity disorder	0.0143	0.0248	CbGeAlD
Gemcitabine—SLC29A1—forebrain—attention deficit hyperactivity disorder	0.0143	0.0248	CbGeAlD
Gemcitabine—POLD1—brain—attention deficit hyperactivity disorder	0.0142	0.0247	CbGeAlD
Gemcitabine—CMPK1—cerebellum—attention deficit hyperactivity disorder	0.014	0.0243	CbGeAlD
Gemcitabine—POLE—nervous system—attention deficit hyperactivity disorder	0.0139	0.0242	CbGeAlD
Gemcitabine—POLE—central nervous system—attention deficit hyperactivity disorder	0.0134	0.0233	CbGeAlD
Gemcitabine—TYMS—Pyrimidine metabolism—DPYD—attention deficit hyperactivity disorder	0.0132	0.0312	CbGpPWpGaD
Gemcitabine—POLE—cerebellum—attention deficit hyperactivity disorder	0.0131	0.0227	CbGeAlD
Gemcitabine—CDA—Nucleotide metabolism—DPYD—attention deficit hyperactivity disorder	0.0126	0.0297	CbGpPWpGaD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0122	0.0289	CbGpPWpGaD
Gemcitabine—SLC29A1—cardiovascular system—attention deficit hyperactivity disorder	0.0121	0.0209	CbGeAlD
Gemcitabine—SLC29A2—brain—attention deficit hyperactivity disorder	0.012	0.0207	CbGeAlD
Gemcitabine—RRM1—midbrain—attention deficit hyperactivity disorder	0.0116	0.0201	CbGeAlD
Gemcitabine—RRM2—nervous system—attention deficit hyperactivity disorder	0.0115	0.0199	CbGeAlD
Gemcitabine—CMPK1—brain—attention deficit hyperactivity disorder	0.0114	0.0197	CbGeAlD
Gemcitabine—POLA1—cerebellum—attention deficit hyperactivity disorder	0.0113	0.0196	CbGeAlD
Gemcitabine—RRM2—central nervous system—attention deficit hyperactivity disorder	0.011	0.0192	CbGeAlD
Gemcitabine—POLE—brain—attention deficit hyperactivity disorder	0.0107	0.0185	CbGeAlD
Gemcitabine—TYMS—midbrain—attention deficit hyperactivity disorder	0.0105	0.0182	CbGeAlD
Gemcitabine—TYMS—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.0102	0.0241	CbGpPWpGaD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00998	0.0236	CbGpPWpGaD
Gemcitabine—RRM1—nervous system—attention deficit hyperactivity disorder	0.00953	0.0165	CbGeAlD
Gemcitabine—RRM1—Nucleotide metabolism—DPYD—attention deficit hyperactivity disorder	0.00952	0.0225	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00928	0.0219	CbGpPWpGaD
Gemcitabine—POLA1—brain—attention deficit hyperactivity disorder	0.00918	0.0159	CbGeAlD
Gemcitabine—RRM1—central nervous system—attention deficit hyperactivity disorder	0.00918	0.0159	CbGeAlD
Gemcitabine—DCK—midbrain—attention deficit hyperactivity disorder	0.00901	0.0156	CbGeAlD
Gemcitabine—RRM1—cerebellum—attention deficit hyperactivity disorder	0.00897	0.0156	CbGeAlD
Gemcitabine—RRM2—brain—attention deficit hyperactivity disorder	0.00877	0.0152	CbGeAlD
Gemcitabine—TYMS—nervous system—attention deficit hyperactivity disorder	0.00864	0.015	CbGeAlD
Gemcitabine—ABCC10—midbrain—attention deficit hyperactivity disorder	0.00858	0.0149	CbGeAlD
Gemcitabine—TYMS—central nervous system—attention deficit hyperactivity disorder	0.00832	0.0144	CbGeAlD
Gemcitabine—TYMS—cerebellum—attention deficit hyperactivity disorder	0.00813	0.0141	CbGeAlD
Gemcitabine—RRM2—Nucleotide metabolism—DPYD—attention deficit hyperactivity disorder	0.00784	0.0185	CbGpPWpGaD
Gemcitabine—SLC29A1—nervous system—attention deficit hyperactivity disorder	0.00775	0.0134	CbGeAlD
Gemcitabine—SLC29A1—central nervous system—attention deficit hyperactivity disorder	0.00746	0.0129	CbGeAlD
Gemcitabine—DCK—nervous system—attention deficit hyperactivity disorder	0.00741	0.0128	CbGeAlD
Gemcitabine—DCK—Nucleotide metabolism—DPYD—attention deficit hyperactivity disorder	0.00733	0.0173	CbGpPWpGaD
Gemcitabine—SLC29A1—cerebellum—attention deficit hyperactivity disorder	0.00729	0.0127	CbGeAlD
Gemcitabine—RRM1—brain—attention deficit hyperactivity disorder	0.00729	0.0126	CbGeAlD
Gemcitabine—DCK—central nervous system—attention deficit hyperactivity disorder	0.00713	0.0124	CbGeAlD
Gemcitabine—DCK—cerebellum—attention deficit hyperactivity disorder	0.00697	0.0121	CbGeAlD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00692	0.0163	CbGpPWpGaD
Gemcitabine—ABCC10—cerebellum—attention deficit hyperactivity disorder	0.00664	0.0115	CbGeAlD
Gemcitabine—TYMS—brain—attention deficit hyperactivity disorder	0.00661	0.0115	CbGeAlD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00622	0.0147	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00594	0.014	CbGpPWpGaD
Gemcitabine—SLC29A1—brain—attention deficit hyperactivity disorder	0.00593	0.0103	CbGeAlD
Gemcitabine—DCK—brain—attention deficit hyperactivity disorder	0.00566	0.00982	CbGeAlD
Gemcitabine—ABCC10—brain—attention deficit hyperactivity disorder	0.00539	0.00935	CbGeAlD
Gemcitabine—TYMS—Nucleotide metabolism—DPYD—attention deficit hyperactivity disorder	0.00514	0.0121	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00507	0.012	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00484	0.0114	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00472	0.0111	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0045	0.0106	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00443	0.0105	CbGpPWpGaD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00426	0.0101	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00423	0.00999	CbGpPWpGaD
Gemcitabine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00375	0.00651	CbGeAlD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00352	0.0083	CbGpPWpGaD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00347	0.0082	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00335	0.00792	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00323	0.00763	CbGpPWpGaD
Gemcitabine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00317	0.0055	CbGeAlD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00274	0.00648	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00272	0.00642	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00268	0.00634	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00267	0.0063	CbGpPWpGaD
Gemcitabine—RRM1—E2F transcription factor network—EP300—attention deficit hyperactivity disorder	0.00265	0.00626	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00258	0.00608	CbGpPWpGaD
Gemcitabine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00248	0.0043	CbGeAlD
Gemcitabine—TYMS—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00245	0.00578	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00241	0.00569	CbGpPWpGaD
Gemcitabine—RRM2—E2F transcription factor network—EP300—attention deficit hyperactivity disorder	0.00218	0.00516	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00217	0.00511	CbGpPWpGaD
Gemcitabine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00204	0.00353	CbGeAlD
Gemcitabine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00196	0.0034	CbGeAlD
Gemcitabine—TYMS—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00196	0.00462	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00196	0.00462	CbGpPWpGaD
Gemcitabine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00192	0.00333	CbGeAlD
Gemcitabine—TYMS—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.0019	0.00448	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00188	0.00443	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00188	0.00443	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00185	0.00436	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00184	0.00435	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00184	0.00433	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00177	0.00417	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00176	0.00415	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00172	0.00406	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00172	0.00405	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00168	0.00397	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00164	0.00387	CbGpPWpGaD
Gemcitabine—ABCB1—brain—attention deficit hyperactivity disorder	0.00156	0.0027	CbGeAlD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00155	0.00365	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00154	0.00364	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.0015	0.00355	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—EP300—attention deficit hyperactivity disorder	0.00149	0.00353	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00148	0.0035	CbGpPWpGaD
Gemcitabine—TYMS—E2F transcription factor network—EP300—attention deficit hyperactivity disorder	0.00143	0.00338	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00143	0.00337	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00127	0.00301	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00123	0.0029	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00122	0.00289	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00116	0.00274	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00116	0.00274	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00114	0.0027	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—COMT—attention deficit hyperactivity disorder	0.00114	0.00269	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00113	0.00267	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00106	0.00251	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00105	0.00248	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00104	0.00246	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00098	0.00231	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000928	0.00219	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000883	0.00209	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000879	0.00208	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000879	0.00208	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000865	0.00204	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000804	0.0019	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000724	0.00171	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000724	0.00171	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00072	0.0017	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00072	0.0017	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000712	0.00168	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000708	0.00167	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000703	0.00166	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—COMT—attention deficit hyperactivity disorder	0.000703	0.00166	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000698	0.00165	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000692	0.00163	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000688	0.00162	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000677	0.0016	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000677	0.0016	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000669	0.00158	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000666	0.00157	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000663	0.00157	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000662	0.00156	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000658	0.00155	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00064	0.00151	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000636	0.0015	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000619	0.00146	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000611	0.00144	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000579	0.00137	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000575	0.00136	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000551	0.0013	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000548	0.00129	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000541	0.00128	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000533	0.00126	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000529	0.00125	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000515	0.00122	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.00049	0.00116	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000488	0.00115	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000487	0.00115	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000479	0.00113	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000475	0.00112	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000475	0.00112	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.00047	0.00111	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000467	0.0011	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000457	0.00108	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000439	0.00104	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000438	0.00103	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000436	0.00103	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000436	0.00103	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000435	0.00103	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000434	0.00102	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000433	0.00102	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.00042	0.000993	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—COMT—attention deficit hyperactivity disorder	0.00041	0.000968	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000407	0.000961	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000379	0.000896	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000361	0.000853	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000335	0.000791	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000321	0.000758	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—EP300—attention deficit hyperactivity disorder	0.000301	0.000712	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.0003	0.000707	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—COMT—attention deficit hyperactivity disorder	0.000288	0.000679	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000287	0.000678	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000285	0.000674	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000228	0.000539	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000223	0.000526	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000212	0.000501	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000205	0.000483	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000188	0.000444	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000187	0.000442	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—EP300—attention deficit hyperactivity disorder	0.000176	0.000415	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000146	0.000346	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000146	0.000346	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000144	0.00034	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000134	0.000316	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—EP300—attention deficit hyperactivity disorder	0.000123	0.000291	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000117	0.000276	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000111	0.000263	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	8.87e-05	0.000209	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.81e-05	0.000208	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	3.8e-05	8.98e-05	CbGpPWpGaD
